What is the projected market valuation for the Intravenous IV Therapy and Vein Access Market in 2035?

The projected market valuation for the Intravenous IV Therapy and Vein Access Market in 2035 is 52.69 USD Billion. Read More

What was the market valuation for the Intravenous IV Therapy and Vein Access Market in 2024?

The market valuation for the Intravenous IV Therapy and Vein Access Market in 2024 was 34.19 USD Billion. Read More

What is the expected CAGR for the Intravenous IV Therapy and Vein Access Market during the forecast period 2025 - 2035?

The expected CAGR for the Intravenous IV Therapy and Vein Access Market during the forecast period 2025 - 2035 is 4.01%. Read More

What are the projected values for Continuous IV Therapy by 2035?

The projected value for Continuous IV Therapy by 2035 is expected to reach 15.0 USD Billion. Read More

How does the market for Peripheral IV Catheters compare to Central Venous Catheters in 2035?

By 2035, the market for Peripheral IV Catheters is projected to be 15.0 USD Billion, while Central Venous Catheters may reach 18.0 USD Billion. Read More

What is the anticipated market size for Fluid Replacement applications by 2035?

The anticipated market size for Fluid Replacement applications by 2035 is 21.69 USD Billion. Read More

What is the projected market value for Adult Patients in the Intravenous IV Therapy and Vein Access Market by 2035?

The projected market value for Adult Patients by 2035 is expected to be 30.0 USD Billion. Read More

What are the expected values for Intraosseous administration routes by 2035?

The expected value for Intraosseous administration routes by 2035 is projected to be 11.69 USD Billion. Read More

What is the market outlook for Pain Management applications in 2035?

The market outlook for Pain Management applications in 2035 suggests a value of 9.0 USD Billion. Read More

Intravenous Therapy Vein Acces Market

Q: Which companies are considered key players in the Intravenous IV Therapy and Vein Access Market?

Key players in the market include Becton Dickinson and Company, Fresenius Kabi AG, Smiths Medical, and Medtronic plc. Read More

ID: MRFR/HC/30731-HCR

100 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Intravenous IV Therapy and Vein Access Market Research Report By IV Therapy Type (Continuous IV Therapy, Intermittent IV Therapy, IV Push Therapy), By Vein Access Device Type (Peripheral IV Catheters, Central Venous Catheters, Midline Catheters), By Application Area (Oncology, Infectious Diseases, Pain Management, Fluid Replacement), By Patient Type (Pediatric Patients, Adult Patients, Geriatric Patients), By Administration Route (Intravenous, Intraosseous) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Intravenous Therapy Vein Acces Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.01%

2024 Market Size$ 34.19 Billion

2025 Market Size$ 35.56 Billion

2035 Market Size$ 52.69 Billion

Key Players

Becton Dickinson and Company

Fresenius Kabi AG

Smiths Medical

Terumo Corporation

Medtronic plc

Vygon S.A.

Trends

Technological Advancements
Shift Towards Outpatient Care
Focus on Patient-Centric Solutions

Opportunities

Regulatory Support and Standards
Focus on Patient-Centric Solutions
Aging Population and Chronic Diseases

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY IV Therapy Type (USD Billion)
  1. 4.1.1 Continuous IV Therapy
  2. 4.1.2 Intermittent IV Therapy
  3. 4.1.3 IV Push Therapy
2. 4.2 Healthcare, BY Vein Access Device Type (USD Billion)
  1. 4.2.1 Peripheral IV Catheters
  2. 4.2.2 Central Venous Catheters
  3. 4.2.3 Midline Catheters
3. 4.3 Healthcare, BY Application Area (USD Billion)
  1. 4.3.1 Oncology
  2. 4.3.2 Infectious Diseases
  3. 4.3.3 Pain Management
  4. 4.3.4 Fluid Replacement
4. 4.4 Healthcare, BY Patient Type (USD Billion)
  1. 4.4.1 Pediatric Patients
  2. 4.4.2 Adult Patients
  3. 4.4.3 Geriatric Patients
5. 4.5 Healthcare, BY Administration Route (USD Billion)
  1. 4.5.1 Intravenous
  2. 4.5.2 Intraosseous
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Becton Dickinson and Company (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Fresenius Kabi AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Smiths Medical (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Terumo Corporation (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Medtronic plc (IE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Vygon S.A. (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 AngioDynamics, Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 B. Braun Melsungen AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Teleflex Incorporated (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY IV THERAPY TYPE
4. 6.4 US MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
5. 6.5 US MARKET ANALYSIS BY APPLICATION AREA
6. 6.6 US MARKET ANALYSIS BY PATIENT TYPE
7. 6.7 US MARKET ANALYSIS BY ADMINISTRATION ROUTE
8. 6.8 CANADA MARKET ANALYSIS BY IV THERAPY TYPE
9. 6.9 CANADA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
10. 6.10 CANADA MARKET ANALYSIS BY APPLICATION AREA
11. 6.11 CANADA MARKET ANALYSIS BY PATIENT TYPE
12. 6.12 CANADA MARKET ANALYSIS BY ADMINISTRATION ROUTE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY IV THERAPY TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
16. 6.16 GERMANY MARKET ANALYSIS BY APPLICATION AREA
17. 6.17 GERMANY MARKET ANALYSIS BY PATIENT TYPE
18. 6.18 GERMANY MARKET ANALYSIS BY ADMINISTRATION ROUTE
19. 6.19 UK MARKET ANALYSIS BY IV THERAPY TYPE
20. 6.20 UK MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
21. 6.21 UK MARKET ANALYSIS BY APPLICATION AREA
22. 6.22 UK MARKET ANALYSIS BY PATIENT TYPE
23. 6.23 UK MARKET ANALYSIS BY ADMINISTRATION ROUTE
24. 6.24 FRANCE MARKET ANALYSIS BY IV THERAPY TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
26. 6.26 FRANCE MARKET ANALYSIS BY APPLICATION AREA
27. 6.27 FRANCE MARKET ANALYSIS BY PATIENT TYPE
28. 6.28 FRANCE MARKET ANALYSIS BY ADMINISTRATION ROUTE
29. 6.29 RUSSIA MARKET ANALYSIS BY IV THERAPY TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
31. 6.31 RUSSIA MARKET ANALYSIS BY APPLICATION AREA
32. 6.32 RUSSIA MARKET ANALYSIS BY PATIENT TYPE
33. 6.33 RUSSIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
34. 6.34 ITALY MARKET ANALYSIS BY IV THERAPY TYPE
35. 6.35 ITALY MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
36. 6.36 ITALY MARKET ANALYSIS BY APPLICATION AREA
37. 6.37 ITALY MARKET ANALYSIS BY PATIENT TYPE
38. 6.38 ITALY MARKET ANALYSIS BY ADMINISTRATION ROUTE
39. 6.39 SPAIN MARKET ANALYSIS BY IV THERAPY TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
41. 6.41 SPAIN MARKET ANALYSIS BY APPLICATION AREA
42. 6.42 SPAIN MARKET ANALYSIS BY PATIENT TYPE
43. 6.43 SPAIN MARKET ANALYSIS BY ADMINISTRATION ROUTE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY IV THERAPY TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY APPLICATION AREA
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY PATIENT TYPE
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY ADMINISTRATION ROUTE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY IV THERAPY TYPE
51. 6.51 CHINA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
52. 6.52 CHINA MARKET ANALYSIS BY APPLICATION AREA
53. 6.53 CHINA MARKET ANALYSIS BY PATIENT TYPE
54. 6.54 CHINA MARKET ANALYSIS BY ADMINISTRATION ROUTE
55. 6.55 INDIA MARKET ANALYSIS BY IV THERAPY TYPE
56. 6.56 INDIA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
57. 6.57 INDIA MARKET ANALYSIS BY APPLICATION AREA
58. 6.58 INDIA MARKET ANALYSIS BY PATIENT TYPE
59. 6.59 INDIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
60. 6.60 JAPAN MARKET ANALYSIS BY IV THERAPY TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
62. 6.62 JAPAN MARKET ANALYSIS BY APPLICATION AREA
63. 6.63 JAPAN MARKET ANALYSIS BY PATIENT TYPE
64. 6.64 JAPAN MARKET ANALYSIS BY ADMINISTRATION ROUTE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY IV THERAPY TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY APPLICATION AREA
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY PATIENT TYPE
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY ADMINISTRATION ROUTE
70. 6.70 MALAYSIA MARKET ANALYSIS BY IV THERAPY TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
72. 6.72 MALAYSIA MARKET ANALYSIS BY APPLICATION AREA
73. 6.73 MALAYSIA MARKET ANALYSIS BY PATIENT TYPE
74. 6.74 MALAYSIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
75. 6.75 THAILAND MARKET ANALYSIS BY IV THERAPY TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
77. 6.77 THAILAND MARKET ANALYSIS BY APPLICATION AREA
78. 6.78 THAILAND MARKET ANALYSIS BY PATIENT TYPE
79. 6.79 THAILAND MARKET ANALYSIS BY ADMINISTRATION ROUTE
80. 6.80 INDONESIA MARKET ANALYSIS BY IV THERAPY TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
82. 6.82 INDONESIA MARKET ANALYSIS BY APPLICATION AREA
83. 6.83 INDONESIA MARKET ANALYSIS BY PATIENT TYPE
84. 6.84 INDONESIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
85. 6.85 REST OF APAC MARKET ANALYSIS BY IV THERAPY TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
87. 6.87 REST OF APAC MARKET ANALYSIS BY APPLICATION AREA
88. 6.88 REST OF APAC MARKET ANALYSIS BY PATIENT TYPE
89. 6.89 REST OF APAC MARKET ANALYSIS BY ADMINISTRATION ROUTE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY IV THERAPY TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
93. 6.93 BRAZIL MARKET ANALYSIS BY APPLICATION AREA
94. 6.94 BRAZIL MARKET ANALYSIS BY PATIENT TYPE
95. 6.95 BRAZIL MARKET ANALYSIS BY ADMINISTRATION ROUTE
96. 6.96 MEXICO MARKET ANALYSIS BY IV THERAPY TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
98. 6.98 MEXICO MARKET ANALYSIS BY APPLICATION AREA
99. 6.99 MEXICO MARKET ANALYSIS BY PATIENT TYPE
100. 6.100 MEXICO MARKET ANALYSIS BY ADMINISTRATION ROUTE
101. 6.101 ARGENTINA MARKET ANALYSIS BY IV THERAPY TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
103. 6.103 ARGENTINA MARKET ANALYSIS BY APPLICATION AREA
104. 6.104 ARGENTINA MARKET ANALYSIS BY PATIENT TYPE
105. 6.105 ARGENTINA MARKET ANALYSIS BY ADMINISTRATION ROUTE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY IV THERAPY TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION AREA
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT TYPE
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY ADMINISTRATION ROUTE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY IV THERAPY TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION AREA
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY PATIENT TYPE
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY ADMINISTRATION ROUTE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY IV THERAPY TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION AREA
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY PATIENT TYPE
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY ADMINISTRATION ROUTE
122. 6.122 REST OF MEA MARKET ANALYSIS BY IV THERAPY TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
124. 6.124 REST OF MEA MARKET ANALYSIS BY APPLICATION AREA
125. 6.125 REST OF MEA MARKET ANALYSIS BY PATIENT TYPE
126. 6.126 REST OF MEA MARKET ANALYSIS BY ADMINISTRATION ROUTE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY IV THERAPY TYPE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY IV THERAPY TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY VEIN ACCESS DEVICE TYPE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY VEIN ACCESS DEVICE TYPE, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY APPLICATION AREA, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY APPLICATION AREA, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY ADMINISTRATION ROUTE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.2.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.2.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.3.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.3.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.4.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.4.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.5.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.5.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.6.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.6.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.7.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.7.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.8.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.8.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.9.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.9.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.10.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.10.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.11.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.11.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.12.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.12.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.13.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.13.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.14.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.14.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.15.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.15.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.16.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.16.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.17.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.17.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.18.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.18.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.19.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.19.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.20.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.20.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.21.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.21.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.22.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.22.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.23.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.23.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.24.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.24.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.25.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.25.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.26.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.26.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.27.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.27.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.28.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.28.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.29.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.29.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
  4. 7.30.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
  5. 7.30.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Intravenous Therapy Vein Acces Market Segmentation

Intravenous Therapy Vein Acces Market By IV Therapy Type (USD Billion, 2025-2035)

Continuous IV Therapy
Intermittent IV Therapy
IV Push Therapy

Intravenous Therapy Vein Acces Market By Vein Access Device Type (USD Billion, 2025-2035)

Peripheral IV Catheters
Central Venous Catheters
Midline Catheters

Intravenous Therapy Vein Acces Market By Application Area (USD Billion, 2025-2035)

Oncology
Infectious Diseases
Pain Management
Fluid Replacement

Intravenous Therapy Vein Acces Market By Patient Type (USD Billion, 2025-2035)

Pediatric Patients
Adult Patients
Geriatric Patients

Intravenous Therapy Vein Acces Market By Administration Route (USD Billion, 2025-2035)

Intravenous
Intraosseous

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035